Home » Stocks » Vapotherm

Vapotherm, Inc. (VAPO)

Stock Price: $30.14 USD -0.64 (-2.06%)
Updated Oct 20, 2020 3:53 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 770.56M
Revenue (ttm) 78.09M
Net Income (ttm) -47.09M
Shares Out 25.57M
EPS (ttm) -2.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 20, 2020
Last Price $30.14
Previous Close $30.77
Change ($) -0.64
Change (%) -2.06%
Day's Open 30.62
Day's Range 30.01 - 31.73
Day's Volume 352,426
52-Week Range 6.86 - 54.42

More Stats

Market Cap 770.56M
Enterprise Value 666.78M
Earnings Date (est) Nov 10, 2020
Ex-Dividend Date n/a
Shares Outstanding 25.57M
Float 14.29M
EPS (basic) -2.24
EPS (diluted) -2.23
FCF / Share -2.25
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.34M
Short Ratio 4.53
Short % of Float 16.37%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 9.87
PB Ratio 5.47
Revenue 78.09M
Operating Income -43.84M
Net Income -47.09M
Free Cash Flow -51.87M
Net Cash 103.78M
Net Cash / Share 4.06
Gross Margin 27.29%
Operating Margin -56.15%
Profit Margin -60.30%
FCF Margin -66.43%
ROA -18.70%
ROE -55.96%
ROIC -61.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(57.06% upside)
Current: $30.14
Target: 47.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth13.51%19.05%18.18%-
Gross Profit21.3116.7713.249.94
Operating Income-48.16-37.23-28.87-22.22
Net Income-51.06-42.47-31.01-23.07
Shares Outstanding18.602.910.690.47
Earnings Per Share-2.74-14.65-44.82-49.38
Operating Cash Flow-39.66-40.02-29.25-25.37
Capital Expenditures-4.75-5.18-5.95-4.53
Free Cash Flow-44.41-45.20-35.19-29.90
Cash & Equivalents73.5160.0228.367.83
Total Debt45.2834.4821.9511.95
Net Cash / Debt28.2325.546.41-4.13
Book Value53.7451.56-127-96.27
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Vapotherm, Inc.
Country United States
Employees 279
CEO Joseph F. Army

Stock Information

Ticker Symbol VAPO
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: VAPO
IPO Date November 14, 2018


Vapotherm, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; tracheostomy adaptors; and ProSoft cannula to provide gentle contact with the skin. In addition, Vapotherm, Inc. offers aerosol disposable patient circuit that is designed to streamline the provision of intermittent and continuous aerosol nebulization by limiting condensate management; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.